Kite Acquires 50% Stake in Cancer Drug Developed by Bay Area Pharma Co Arcellx

Santa Monica-based cell therapy pharma company Kite has agreed to purchase a stake in the lead cancer drug candidate of Redwood City-based pharma company Arcellx Inc. Kite will pay $225 million in cash and $100 million in equity investment,